The platelet membrane glycoprotein VI genetic polymorphism (rs1613662, 13254T&#x003E;C) is not associated with the risk of coronary artery disease

Jian-Quan Luo; Huan Ren; Mou-Ze Liu; Ping-Fei Fang; Da-Xiong Xiang

doi:10.18632/oncotarget.23427

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 01/02/2018.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

The platelet membrane glycoprotein VI genetic polymorphism (rs1613662, 13254T>C) is not associated with the risk of coronary artery disease

Jian-Quan Luo _, Huan Ren, Mou-Ze Liu, Ping-Fei Fang and Da-Xiong Xiang

Jian-Quan Luo1,2,*, Huan Ren3,*, Mou-Ze Liu1,2, Ping-Fei Fang1,2 and Da-Xiong Xiang1,2

1Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P. R. China

2Institute of Clinical Pharmacy, Central South University, Changsha, Hunan 410011, P. R. China

3Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, P. R. China

*These authors contributed equally to this work

Correspondence to:

Jian-Quan Luo, email: [email protected]

Keywords: glycoprotein VI; platelets; genetic association; polymorphism; coronary artery disease

Received: June 01, 2017 Accepted: November 28, 2017 Epub: January 02, 2018

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23427

Publication Alerts

Withdrawal Notice

Research Papers:

The platelet membrane glycoprotein VI genetic polymorphism (rs1613662, 13254T>C) is not associated with the risk of coronary artery disease